FDA product code QAA: Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens

QAA is the FDA product code for coccidioides spp. nucleic acid detection system for respiratory specimens. It is a Class II device, regulated under 21 CFR 866.3376 and reviewed by the Microbiology panel. Devices under QAA reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

A Coccidioides spp. nucleic acid detection system for respiratory specimens is a qualitative test for the detection of Coccidioides spp. nucleic acids directly in clinical respiratory specimens from patients with signs and symptoms of coccidioidomycosis and suspicion of infection.

Classification

FieldValue
Device nameCoccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens
Device classClass II
Regulation21 CFR 866.3376
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

Recalls for QAA devices

openFDA lists no recalls for product code QAA.

Frequently asked questions

What is FDA product code QAA?

QAA is the FDA product code for coccidioides spp. nucleic acid detection system for respiratory specimens. It is a Class II device, regulated under 21 CFR 866.3376 and reviewed by the Microbiology panel.

What device class is QAA?

Class II, regulation 21 CFR 866.3376. Typical premarket route: 510(k).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times